Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Primidone 62.5mg/5ml oral suspension
0408010U0AABBBB
|
Primidone | Primidone | Central Nervous System | 40 |
|
Chloral hydrate 200mg/5ml oral solution BP
0401010B0AABXBX
|
Chloral hydrate | Chloral hydrate | Central Nervous System | 39 |
|
Entacapone 200mg/5ml oral suspension
0409010V0AAACAC
|
Entacapone | Entacapone | Central Nervous System | 39 |
|
Fluphenazine decanoate 25mg/1ml inj ampoules
0402020L0AAACAC
|
Fluphenazine decanoate | Fluphenazine decanoate | Central Nervous System | 39 |
|
Tuinal 100mg Pulvules
0401030T0BCAAAC
|
Tuinal | Secobarbital sodium | Central Nervous System | 39 |
|
Zydol XL 300mg tablets
040702040BBAIAM
|
Zydol | Tramadol hydrochloride | Central Nervous System | 39 |
|
Clonazepam 250micrograms/5ml oral solution
0408010F0AABCBC
|
Clonazepam (Systemic) | Clonazepam | Central Nervous System | 38 |
|
Dihydrocodeine 10mg/5ml oral suspension
0407020G0AAAPAP
|
Dihydrocodeine tartrate | Dihydrocodeine tartrate | Central Nervous System | 38 |
|
Hydromorphone 16mg modified-release capsules
040702050AAAAAA
|
Hydromorphone hydrochloride | Hydromorphone hydrochloride | Central Nervous System | 38 |
|
Eroset 500mg/10mg tablets
0407010N0BIAAAA
|
Eroset | Co-dydramol (Dihydrocodeine/paracetamol) | Central Nervous System | 37 |
|
Paracetamol 1g/100ml solution for infusion vials
0407010H0AADIDI
|
Paracetamol | Paracetamol | Central Nervous System | 37 |
|
Ropiqual XL 4mg tablets
0409010H0BKABAL
|
Ropiqual | Ropinirole hydrochloride | Central Nervous System | 37 |
|
Xeomin 100unit powder for solution for injection vials
0409030B0BEAAAE
|
Xeomin | Botulinum toxin type A | Central Nervous System | 37 |
|
Xeplion 50mg/0.5ml prolonged-release inj pf syringes
0402020ABBBAAAA
|
Xeplion | Paliperidone | Central Nervous System | 37 |
|
Zofran Melt 4mg oral lyophilisates
0406000S0BBAIAI
|
Zofran | Ondansetron hydrochloride | Central Nervous System | 37 |
|
Duciltia 30mg gastro-resistant capsules
0403040Y0BCAAAA
|
Duciltia (Antidepressant) | Duloxetine hydrochloride | Central Nervous System | 36 |
|
Ixyldone 10mg modified-release tablets
0407020ADBTABAF
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 36 |
|
Ontozry 100mg tablets
0408010ANBBABAB
|
Ontozry | Cenobamate | Central Nervous System | 36 |
|
Oxylan 80mg prolonged-release tablets (G.L. Pharma UK Ltd)
0407020ADBFAEAI
|
Oxylan | Oxycodone hydrochloride | Central Nervous System | 36 |
|
Palladone SR 8mg capsules
040702050BBAEAC
|
Palladone | Hydromorphone hydrochloride | Central Nervous System | 36 |
|
Raponer XL 4mg tablets
0409010H0BGABAL
|
Raponer XL | Ropinirole hydrochloride | Central Nervous System | 36 |
|
Actimorph 30mg orodispersible tablets
0407020Q0BQAEGI
|
Actimorph | Morphine sulfate | Central Nervous System | 35 |
|
Galantamine 8mg tablets
0411000F0AAABAB
|
Galantamine | Galantamine | Central Nervous System | 35 |
|
Hyoscine hydrobromide 500micrograms/5ml oral solution
0406000L0AABPBP
|
Hyoscine hydrobromide (Systemic) | Hyoscine hydrobromide | Central Nervous System | 35 |
|
Lorazepam 4mg/1ml solution for injection ampoules
0401020P0AAAAAA
|
Lorazepam | Lorazepam | Central Nervous System | 35 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.